<DOC>
	<DOCNO>NCT00852670</DOCNO>
	<brief_summary>This study ass efficacy , safety , tolerability ACT-128800 subject moderate severe plaque psoriasis .</brief_summary>
	<brief_title>ACT-128800 Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Adult male female moderate severe plaque psoriasis require systemic treatment participation placebocontrolled study investigational drug justify . Patients forms psoriasis patient currently treat autoimmune disorder psoriasis . Systemic topical treatment psoriasis emollient . Ongoing bacterial , viral fungal infection . History presence malignancy . Additional inclusion exclusion criterion apply respect medical condition concomitant treatment could affect patient ' risk participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>